Astec LifeSciences Ltd Stock Price Today (NSE: ASTEC)
Fundamental Score
Astec LifeSciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Astec LifeSciences Ltd share price today is ₹787.90, up +6.73% on NSE/BSE as of 18 June 2026. Astec LifeSciences Ltd (ASTEC) is a Small-cap company in the Pesticides & Agrochemicals sector with a market capitalisation of ₹1.82K (Cr). The 52-week high for ASTEC share price is ₹998.40 and the 52-week low is ₹513.40. The company has a Return on Equity (ROE) of -45.29% and a debt-to-equity ratio of 0.89.
Astec LifeSciences Ltd Share Price Chart — NSE/BSE Historical Performance
Astec LifeSciences Ltd share price chart: 1.51% return over the past month. 52-week high ₹998.40, 52-week low ₹513.40.
Astec LifeSciences Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹727.20 | ₹822.75 | ₹722.60 | ₹787.90 | 3.66L (Cr) | |
| ₹769.70 | ₹773.00 | ₹732.50 | ₹738.25 | 38.80K (Cr) | |
| ₹763.50 | ₹850.00 | ₹755.65 | ₹770.95 | 5.86L (Cr) | |
| ₹749.00 | ₹785.00 | ₹743.55 | ₹761.25 | 77.65K (Cr) | |
| ₹752.90 | ₹769.80 | ₹742.30 | ₹746.95 | 36.62K (Cr) | |
| ₹775.00 | ₹775.35 | ₹750.00 | ₹752.90 | 37.11K (Cr) | |
| ₹742.30 | ₹788.15 | ₹723.90 | ₹771.80 | 1.20L (Cr) | |
| ₹758.00 | ₹758.95 | ₹731.00 | ₹736.65 | 41.58K (Cr) | |
| ₹737.95 | ₹778.65 | ₹724.90 | ₹751.55 | 1.17L (Cr) | |
| ₹748.00 | ₹761.85 | ₹723.00 | ₹738.75 | 1.97L (Cr) |
Astec LifeSciences Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹769.70 | ₹822.75 | ₹722.60 | ₹787.90 | +2.36% | |
| ₹694.70 | ₹850.00 | ₹647.95 | ₹770.95 | +10.98% | |
| ₹564.00 | ₹769.70 | ₹534.00 | ₹694.70 | +23.17% | |
| ₹616.00 | ₹649.00 | ₹513.40 | ₹540.60 | -12.24% | |
| ₹571.00 | ₹682.00 | ₹562.40 | ₹623.70 | +9.23% | |
| ₹715.00 | ₹729.00 | ₹557.00 | ₹575.00 | -19.58% | |
| ₹826.05 | ₹867.80 | ₹697.10 | ₹705.00 | -14.65% | |
| ₹669.00 | ₹941.75 | ₹607.05 | ₹837.90 | +25.25% | |
| ₹796.65 | ₹847.00 | ₹655.00 | ₹660.05 | -17.15% | |
| ₹883.60 | ₹905.30 | ₹788.50 | ₹804.70 | -8.93% | |
| ₹902.00 | ₹933.85 | ₹780.20 | ₹872.70 | -3.25% | |
| ₹918.23 | ₹978.30 | ₹833.60 | ₹906.30 | -1.30% |
AI Research Briefing
Powered by Gemini · 2026-04-09
Small-cap agrochem turnaround story hinges on CDMO growth, but past losses and high debt are major concerns.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Astec LifeSciences experienced a volatile period. On March 23, 2026, the stock declined to a 52-week low of However, it showed signs of stabilization with a modest recovery on March 24, 2026, closing at For the week ending March 27, 2026, the stock gained 4.07%, closing at , outperforming the Sensex.
CORE STORY (THE REAL GAME)
Astec is a play on the Indian agrochemical industry, specifically riding on contract manufacturing and exports. The market narrative is a turnaround story, betting on improved CDMO offtake and new herbicide manufacturing to diversify from triazole fungicides.
- Q3 FY26 showed strong revenue growth driven by CDMO and enterprise volumes
- EBITDA turned positive in Q3 FY26 at ₹4.8 crore
- Stock has recovered from 52-week low, showing some resilience
- Significant new order wins in the CDMO segment
- Successful diversification into new product lines like herbicides
- Improvement in operating margins and reduction in debt
- Small-cap: liquidity risk
- History of operating losses and negative free cash flow
- High debt-to-equity ratio and insufficient earnings to cover interest expenses
Promoter holding increased by 1.55% [cite: Brief]. FII and DII holdings decreased [cite: Brief].
Agrochemicals market in India is projected to grow, but susceptible to monsoon vagaries.
No - Free Cash Flow 5Y: ₹-381.94 Cr [cite: Brief]
Monitor CDMO growth and margin improvement over the next 2 quarters. Successful diversification into new products is key.
Primary Thesis Risk
Failure to turnaround operations and manage debt will lead to collapse.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Astec LifeSciences Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Astec LifeSciences Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ASTEC across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (36.64%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Balanced Promoter Holding (72.42%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-45.29%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-12.86%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Revenue Contraction (-25.20%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-6.11% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-1.47x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-381.94 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.01%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Astec LifeSciences Ltd vs Pesticides & Agrochemicals Peers
Peer Comparison - Pesticides & Agrochemicals
Compare Astec LifeSciences Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Astec LifeSciences LtdAstec LifeScien...Selected✓ ASTEC • 533138 | 17/100 | ₹787.90₹788 | ₹1818.40₹1818.40 | — — | -45.29%Poor -45.29% Poor | -12.86%Poor -12.86% Poor | 0.89Good 0.9 Good | — — | -6.11%Poor -6.11% Poor | 0.00% |
UPL LtdUPL Ltd... UPL • 512070 | 29.8/100 | ₹656.15₹656 | ₹63303.75₹63303.75 | 26.68Average 26.7 Average | 3.29%Poor 3.29% Poor | 7.66%Poor 7.66% Poor | 0.94Good 0.9 Good | -16.10%Poor -16.10% Poor | 5.46%Good 5.46% Good | 0.80% |
PI Industries LtdPI Industries L... PIIND • 523642 | 63.8/100 | ₹2847.30₹2847 | ₹51402.12₹51402.12 | 33.98Average 34.0 Average | 17.61%Good 17.61% Good | 22.86%Excellent 22.86% Excellent | 0.02Excellent 0.0 Excellent | 29.53%Excellent 29.53% Excellent | 18.83%Excellent 18.83% Excellent | 0.47% |
Sumitomo Chemical India LtdSumitomo Chemic... SUMICHEM • 542920 | 51.9/100 | ₹495.50₹496 | ₹23622.23₹23622.23 | 43.71Average 43.7 Average | 18.81%Good 18.81% Good | 25.14%Excellent 25.14% Excellent | 0.02Excellent 0.0 Excellent | 17.27%Excellent 17.27% Excellent | 4.98%Average 4.98% Average | 0.25% |
Bayer CropScience LtdBayer CropScien... BAYERCROP • 506285 | 46/100 | ₹4615.80₹4616 | ₹20761.67₹20761.67 | 34.10Average 34.1 Average | 19.96%Good 19.96% Good | 24.80%Excellent 24.80% Excellent | 0.03Excellent 0.0 Excellent | -0.06%Poor -0.06% Poor | 8.68%Good 8.68% Good | 2.71% |
Sharda Cropchem LtdSharda Cropchem... SHARDACROP • 538666 | 68.3/100 | ₹934.80₹935 | ₹7868.22₹7868.22 | 17.41Average 17.4 Average | 12.62%Average 12.62% Average | 16.50%Good 16.50% Good | 0.00Excellent 0.0 Excellent | 8.25%Good 8.25% Good | 16.62%Excellent 16.62% Excellent | 1.03% |
Dhanuka Agritech LimitedDhanuka Agritec... DHANUKA • 507717 | 56.7/100 | ₹1180.30₹1180 | ₹5600.99₹5600.99 | 20.00Average 20.0 Average | 21.95%Excellent 21.95% Excellent | 28.29%Excellent 28.29% Excellent | 0.02Excellent 0.0 Excellent | 15.69%Excellent 15.69% Excellent | 12.69%Good 12.69% Good | 0.16% |
Rallis India LtdRallis India Lt... RALLIS • 500355 | 28.4/100 | ₹250.60₹251 | ₹5133.00₹5133.00 | 30.06Average 30.1 Average | 6.65%Poor 6.65% Poor | 10.12%Average 10.12% Average | 0.03Excellent 0.0 Excellent | -6.88%Poor -6.88% Poor | 3.41%Average 3.41% Average | 0.95% |
Bharat Rasayan LtdBharat Rasayan ... BHARATRAS • 590021 | 32.4/100 | ₹1488.70₹1489 | ₹4344.48₹4344.48 | 31.32Average 31.3 Average | 11.09%Average 11.09% Average | 14.33%Average 14.33% Average | 0.08Excellent 0.1 Excellent | -6.27%Poor -6.27% Poor | -0.71%Poor -0.71% Poor | 0.01% |
NACL Industries LtdNACL Industries... NACLIND • 524709 | 0/100 | ₹161.43₹161 | ₹3826.07₹3826.07 | — — | -25.75%Poor -25.75% Poor | -7.80%Poor -7.80% Poor | 1.13Average 1.1 Average | — — | 4.00%Average 4.00% Average | 0.00% |
Bhagiradha Chemicals & Industries LimitedBhagiradha Chem... BHAGCHEM • 531719 | 31.2/100 | ₹244.65₹245 | ₹3163.13₹3163.13 | 259.49Average 259.5 Average | 2.53%Poor 2.53% Poor | 5.19%Poor 5.19% Poor | 0.27Excellent 0.3 Excellent | 22.42%Excellent 22.42% Excellent | 12.39%Good 12.39% Good | 0.06% |
Top Pesticides & Agrochemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- UPL Ltd share price63303.75 Cr
- PI Industries Ltd share price51402.12 Cr
- Sumitomo Chemical India Ltd share price23622.23 Cr
- Bayer CropScience Ltd share price20761.67 Cr
- Sharda Cropchem Ltd share price7868.22 Cr
Astec LifeSciences Ltd PE Ratio History
Historical price-to-earnings ratio for ASTEC — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹12.94 | ₹1095.25 | 84.6x |
| FY 2022 | ₹45.50 | ₹1751.00 | 38.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Astec LifeSciences Ltd Dividend History
Annual cash dividends paid by ASTEC — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2024 | ₹2.94 Cr |
| FY 2023 | ₹2.94 Cr |
| FY 2022 | ₹2.94 Cr |
| FY 2021 | ₹2.94 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Astec LifeSciences Ltd Quarterly Performance
Latest quarterly metrics for ASTEC — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-25.20%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
36.64%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-6.11%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Astec LifeSciences Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ASTEC — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Astec LifeSciences Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Astec LifeSciences Ltd (ASTEC) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Astec LifeSciences Ltd
About ASTEC (Astec LifeSciences Ltd)
Astec LifeSciences Ltd is a pivotal player in the agrochemical sector, specializing in the meticulous creation of essential ingredients that underpin modern agriculture. The compan...y's expertise lies in synthesizing active ingredients for crop protection products, primarily focusing on triazole fungicides. These compounds are instrumental in safeguarding a wide spectrum of crops from fungal diseases, contributing to improved yields and reduced post-harvest losses. Astec meticulously engineers its products to meet the stringent demands of the agricultural industry, ensuring both efficacy and environmental responsibility. Through constant innovation and a commitment to sustainable practices, Astec LifeSciences strengthens its position as a reliable supplier for global crop protection companies. Beyond fungicides, Astec LifeSciences also produces a range of specialized chemical intermediates vital to the pharmaceutical industry. These intermediates serve as key building blocks for complex drug molecules, showcasing the company's versatile chemistry capabilities. This dual focus on agrochemicals and pharmaceutical intermediates positions Astec as a significant contributor to both food security and human health. The company invests significantly in research and development, constantly seeking to refine its processes and develop novel compounds that address emerging challenges in both agricultural and pharmaceutical sectors. Astec understands the importance of quality and precision in its manufacturing processes, assuring that its outputs adhere to the highest industry standards. Operating within India, Astec LifeSciences leverages its local expertise and infrastructure to serve a global clientele. The company strategically cultivates its strong relationships with both domestic and international clients. Astec's commitment to reliable supply chains, combined with a deep understanding of the agrochemical and pharmaceutical markets, makes it a trusted partner for organizations seeking high-quality chemical solutions. With its blend of scientific expertise, manufacturing proficiency, and a focus on responsible business practices, Astec LifeSciences contributes significantly to advancing agricultural productivity and pharmaceutical innovation.
Company Details
Key Leadership
Corporate Events
ASTEC Share Price: Frequently Asked Questions
What is the current share price of Astec LifeSciences Ltd?
Astec LifeSciences Ltd (ASTEC) trades at ₹787.90 on NSE and BSE. Market cap ₹1.82K (Cr). Educational data only.
What is the P/E ratio of Astec LifeSciences Ltd?
Astec LifeSciences Ltd has a P/E of N/Ax vs industry average 29.36x.
What is the Bull Run score for Astec LifeSciences Ltd?
Astec LifeSciences Ltd has a Bull Run score of 17/100 based on 25+ financial parameters.
Does Astec LifeSciences Ltd pay dividends?
Astec LifeSciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Astec LifeSciences Ltd?
Astec LifeSciences Ltd has ROE of -45.29%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Astec LifeSciences Ltd?
Astec LifeSciences Ltd has debt-to-equity of 0.89.
Is Astec LifeSciences Ltd a good investment?
Bull Run gives Astec LifeSciences Ltd a score of 17/100. This is not investment advice — consult a SEBI-registered advisor.